BA
AXNX

Bridgewater Associates’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bridgewater Associates’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,016
Closed -$1.39M – 855
2024
Q3 		$1.39M Sell
20,016
-22,603
-53% -$1.55M 0.01% 555
2024
Q2 		$2.87M Sell
42,619
-3,880
-8% -$261K 0.02% 466
2024
Q1 		$3.21M Sell
46,499
-7,657
-14% -$517K 0.02% 431
2023
Q4 		$3.37M Sell
54,156
-6,143
-10% -$344K 0.02% 431
2023
Q3 		$3.38M Buy
60,299
+5,528
+10% +$311K 0.02% 416
2023
Q2 		$2.76M Sell
54,771
-5,774
-10% -$307K 0.02% 418
2023
Q1 		$3.3M Buy
60,545
+2,621
+5% +$153K 0.02% 376
2022
Q4 		$3.62M Sell
57,924
-17,798
-24% -$1.18M 0.02% 424
2022
Q3 		$5.33M Buy
75,722
+12,535
+20% +$865K 0.03% 369
2022
Q2 		$3.58M Buy
63,187
+10,205
+19% +$559K 0.02% 577
2022
Q1 		$3.32M Buy
52,982
+13,002
+33% +$701K 0.01% 560
2021
Q4 		$2.24M Sell
39,980
-3,124
-7% -$191K 0.01% 449
2021
Q3 		$2.81M Sell
43,104
-3,374
-7% -$230K 0.02% 381
2021
Q2 		$2.95M Buy
+46,478
New +$2.74M 0.02% 427

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Bridgewater Associates's AXNX Position: Q4 2024 in Review

Bridgewater Associates sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 20,016 shares — an estimated $1.39M sold.

Bridgewater Associates first reported a position in AXNX in Q2 2021 and held it in 14 quarters. The position peaked at $5.33M in Q3 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Bridgewater Associates reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Bridgewater Associates sold 20,016 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $1.39M.
  • Bridgewater Associates first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 14 quarters.
  • Bridgewater Associates's Axonics, Inc. Common Stock position peaked at $5.33M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.